Quote:

---

So many companies get a price pop on good data, then a slow or fast slide back down to baseline. It's a slog, even though Leronlimab is safe and even though we're trying to help people.

---

Do you believe $.11-.12 is a fair and reasonable baseline?

If you answer “no” then you should agree with Figgs’ sentiment.